Renal excretion profiles of psilocin following oral administration of psilocybin: a controlled study in man. (Q34145595)

31 July 2017

Renal excretion profiles of psilocin following oral administration of psilocybin: a controlled study in man. (English)

1 reference

31 July 2017

1 reference

Felix Hasler

1

1 reference

31 July 2017

Daniel Bourquin

series ordinal

2

1 reference

31 July 2017

Rudolf Brenneisen

series ordinal

3

1 reference

31 July 2017

Franz X Vollenweider

series ordinal

4

1 reference

31 July 2017

1 September 2002

1 reference

31 July 2017

9

1 reference

Journal of Pharmaceutical and Biomedical Analysis

inferred from page(s)

published in

1 reference

31 July 2017

30

1 reference

31 July 2017

2

1 reference

31 July 2017

331-339

1 reference

Psychoactive mushroom use in Koh Samui and Koh Pha-Ngan, Thailand

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2802%2900278-9

7 January 2021

Adolescent drug use in Wales

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2802%2900278-9

7 January 2021

Increasing use of "Ecstasy" (MDMA) and other hallucinogens on a college campus

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2802%2900278-9

7 January 2021

Increased activation of indirect semantic associations under psilocybin

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2802%2900278-9

7 January 2021

Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2802%2900278-9

7 January 2021

Effects of the hallucinogen psilocybin on habituation and prepulse inhibition of the startle reflex in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2802%2900278-9

7 January 2021

Advances and pathophysiological models of hallucinogenic drug actions in humans: a preamble to schizophrenia research.

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2802%2900278-9

7 January 2021

Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2802%2900278-9

7 January 2021

Neurometabolic effects of psilocybin, 3,4-methylenedioxyethylamphetamine (MDE) and d-methamphetamine in healthy volunteers. A double-blind, placebo-controlled PET study with [18F]FDG.

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2802%2900278-9

7 January 2021

Psychopathological, neuroendocrine and autonomic effects of 3,4-methylenedioxyethylamphetamine (MDE), psilocybin and d-methamphetamine in healthy volunteers. Results of an experimental double-blind placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2802%2900278-9

7 January 2021

5-HT modulation of dopamine release in basal ganglia in psilocybin-induced psychosis in man--a PET study with [11C]raclopride.

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2802%2900278-9

7 January 2021

Determination of psilocin and 4-hydroxyindole-3-acetic acid in plasma by HPLC-ECD and pharmacokinetic profiles of oral and intravenous psilocybin in man

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2802%2900278-9

7 January 2021

Quantitation of psilocin in human plasma by high-performance liquid chromatography and electrochemical detection: comparison of liquid-liquid extraction with automated on-line solid-phase extraction

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2802%2900278-9

7 January 2021

The fate of psilocin in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2802%2900278-9

7 January 2021

Detection of psilocin in body fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2802%2900278-9

7 January 2021

Determination of psilocin in rat urine by high-performance liquid chromatography with electrochemical detection

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2802%2900278-9

7 January 2021

Analytical methods validation: Bioavailability, bioequivalence and pharmacokinetic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2802%2900278-9

7 January 2021

10.1016/S0731-7085(02)00278-9

Identifiers

DOI

1 reference

31 July 2017

1 reference